We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 104

Who’s Kidding Who?
  • Oblon
  • USA
  • June 18 2018

A Feature Article of Law360 entitled “Ex-PTAB Judges Say Board Policies Don’t Squelch Dissents,” by Ryan Davis, argued that policies of the Patent


Decs, Slides, and Videotape: Utilizing non-patent literature in IPR
  • Oblon
  • USA
  • June 18 2018

In Medtronic, Inc. v. Barry (2017-1169 and 2017-1170), the Federal Circuit (Circuit Judges Taranto, Plager, and Chen, decision authored by Judge Chen


Jurisdiction for “Late Listed” Orange Book Patent and Injunction Based on Induced Infringement by Drug Label
  • Oblon
  • USA
  • April 25 2018

As reported earlier, the Federal Circuit in Vanda Pharm. Inc. v. West-Ward Pharm. Int’l. Ltd. held that jurisdiction exists under 35 U.S.C.


USPTO Issues Memorandum and Publishes Fed Reg Notice for Comment Regarding 101 Eligibility
  • Oblon
  • USA
  • April 23 2018

On April 20, 2018, the USPTO published ( in the Federal Register a “Request for


Federal Circuit clarifies standard for proper venue in patent cases
  • Oblon
  • USA
  • September 22 2017

As we discussed last month link to previous post, various district courts across the U.S. have been applying the statutory “regular and established


Cleveland Clinic - Part 1
  • Oblon
  • USA
  • September 12 2017

In Cleveland Clinic Found. V. True Health Diagnostics, LLC, 859 F.3d 1352 (2017) the Federal Circuit affirmed a finding that a method of


Federal Circuit Affirms ITC Exclusion Order In Viraj Appeal (2016-2482)
  • Oblon
  • USA
  • September 12 2017

On September 11, 2017, the U.S. Court of Appeals for the Federal Circuit ("Federal Circuit") issued a judgment without opinion affirming the decision


Proper venue, a developing story
  • Oblon
  • USA
  • August 21 2017

The U.S. patent venue statute states that a patent litigation may be filed in the judicial district where (1) the defendant resides, or (2) the


HELSINN - The USPTO and Federal Circuit are both wrong
  • Oblon
  • USA
  • August 21 2017

The USPTO has asserted that under the AIA secret sales or use of an invention do not invalidate a patent. See Fed. Reg., Vol. 78. No. 31, 11059 at


Decision Upholding Subject Matter Eligibility: Visual Memory v. NVIDIA (Fed. Cir., August 2017)
  • Oblon
  • USA
  • August 15 2017

With every major patent blog reporting on the recent Federal Circuit decision (favorable to patent owners) to reverse a district court judgement that